Express Pharma

Strides Arcolab receives USFDA nod for oral dosage facility

0 98

Last USFDA inspection and approval for this facility in 2011
 

Strides Arcolab’s Oral Dosage Forms manufacturing site (KRS Gardens) in Bangalore was recently inspected by the USFDA as part of GMP compliance audit and was granted approval. 
The last USFDA inspection and approval for this facility was in the year 2011.
 
The KRS Gardens facility in Bangalore manufactures oral dosage forms such as tablets, capsules (both hard gelatine and soft gelatine) and sachets.  The manufacturing plant supports important current and future submissions for the US Market.
 
Strides Arcolab, listed on the Bombay Stock Exchange Limited (532531) and National Stock Exchange of India Limited (STAR), is a global pharmaceutical Company headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceutical products. The Company has 5 manufacturing facilities presence in more than 75 countries in developed and emerging markets.
 
 

EP News Bureau

- Advertisement -

Leave A Reply

Your email address will not be published.